Abstract: The invention relates to a dosage projectile for administering an active agent to an animal, the projectile configured to contain an active agent and having a frangible shell adapted to fragment on impact with an animal to deliver the active agent to the animal and produce a plurality of shell fragments associated with the animal after impact to provide a visible mark on the animal.

Abstract: The invention relates to a dosage projectile for administering an active agent to an animal, the projectile configured to contain an active agent and having a frangible shell adapted to fragment on impact with an animal to deliver the active agent to the animal and produce a plurality of shell fragments associated with the animal after impact to provide a visible mark on the animal.

Abstract: A remote treatment delivery system for an animal including a dosage projectile adapted to deliver a biologically active agent to an animal substantially without piercing the skin of the animal and containing a biologically active agent and a carrier in liquid or gel form, the carrier allows adhesion of the biologically active agent to skin, coat or fur of the animal; wherein the agent and the carrier are encapsulated in one or more encapsulating agents; and wherein the encapsulating agents forms a frangible shell.

Abstract: The invention relates to a dosage regime for treating an animal over a pest season, the dosage regime comprising a first dosage projectile having a unique identifier and containing a first pesticide; a second dosage projectile having a unique identifier and containing a second pesticide; and a third dosage projectile having a unique identifier and containing a third pesticide; wherein the dosage projectiles are configured for remotely delivering the pesticides to an animal; and wherein the unique identifiers indicate the timing of administration of each pesticide over a pest season. The invention also relates to use of the dosage regime to treat an animal over a pest season.

Abstract: A remote treatment delivery system for an animal including a dosage projectile adapted to deliver a biologically active agent to an animal substantially without piercing the skin of the animal and containing a biologically active agent and a carrier in liquid or gel form, the carrier allows adhesion of the biologically active agent to skin, coat or fur of the animal; wherein the agent and the carrier are encapsulated in one or more encapsulating agents; and wherein the encapsulating agents forms a frangible shell.

Abstract: A method of remotely treating an animal including launching a delivery system at the animal, wherein the delivery system comprises a dosage projectile adapted to deliver a biologically active agent to an animal substantially without piercing the skin of the animal and containing a biologically active agent and a transdermal carrier in liquid or gel form, wherein the agent and the carrier are encapsulated in one or more encapsulating agents, and wherein the encapsulating agents forms a frangible shell; impacting the projectile on the animal to release the biologically active agent and the transdermal carrier from the frangible shell substantially without piercing the skin of the animal; and delivering the biologically active agent to the animal, wherein the transdermal carrier facilitates passage of the biologically active agent across the skin of the animal to provide treatment to the animal.

Abstract: A launcher for remotely treating an animal is described. The launcher having a first chamber adapted to receive a first dosage projectile having a first calibre, a second chamber adapted to receive a second dosage projectile having a second caliber smaller than the first calibre, a launcher barrel comprising a first cooperating caliber facilitating launching of the first dosage projectile, an adaptor comprising a second cooperating caliber facilitating launching of the second dosage projectile, and a propulsion assembly for propelling the dosage projectiles. An adaptor is also described, for adapting the launcher to launch dosage projectiles of calibers other than those associated with the launcher barrel.

Abstract: A remote treatment delivery system comprising a substantially non-skin piercing dosage projectile containing a biologically active agent and a transdermal carrier.

Abstract: A remote treatment delivery system comprising a substantially non-skin piercing dosage projectile containing a biologically active agent and a transdermal carrier.